5 HSCT Articles You Can’t Miss


5. Stem Cell Transplantation Benefits 94% of Diffuse Cutaneous SSc Patients

Stem Cell Transplantation

Autologous haematopoietic stem cell transplantation (AHSCT) has become quite popular for treating patients with systemic sclerosis (SSc). Popularity aside, a limited number of clinical trials had prevented researchers from investigating long-term outcomes of AHSCT in patients with severe diffuse cutaneous SSc.


Here are some scleroderma-related conditions you should watch for, according to the Scleroderma Foundation.

Scleroderma News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

Leave a Comment

Your email address will not be published. Required fields are marked *